Earnings Call · Q4 FY2022·2023-02-08

Q4 22EPS -13.04%·Rev n/aQ3 22EPS +8.70%·Rev n/aQ2 22EPS -9.52%·Rev n/aQ1 22EPS -10.53%·Rev n/a⚠ consensus missing

Viking Therapeutics, Inc. VKTX

−4.0%1d on move date−2.9% vs SPY3d+7.1%5d+8.1%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VKTX calls or request research access.

More VKTX calls Browse calls Request research access